Our studies demonstrated that SPARCL1 significantly correlated with clinicopathological features, overall survival, and tumor microenvironment in CRC, which might help us better understanding the roles of SPARCL1 in CRC. The gene discussed is SPARCL1; the disease is colorectal carcinoma.